Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020

Tobias M Holden, Reese A.K. Richardson, Philip Arevalo, Wayne A. Duffus, Manuela Runge, Elena Whitney, Leslie Wise, Ngozi O. Ezike, Sarah Patrick, View ORCID ProfileSarah Cobey, View ORCID ProfileJaline Gerardin
doi: https://doi.org/10.1101/2021.04.14.21255476
Tobias M Holden
1Northwestern University Feinberg School of Medicine, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reese A.K. Richardson
2Department of Chemical and Biological Engineering, Northwestern University, Evanston IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Arevalo
3Department of Ecology and Evolutionary Biology, University of Chicago, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne A. Duffus
4Center for Preparedness and Response, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta GA
5Illinois Department of Public Health, Springfield IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Runge
6Department of Preventive Medicine and Institute for Global Health, Northwestern University, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Whitney
3Department of Ecology and Evolutionary Biology, University of Chicago, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie Wise
5Illinois Department of Public Health, Springfield IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ngozi O. Ezike
5Illinois Department of Public Health, Springfield IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Patrick
5Illinois Department of Public Health, Springfield IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Cobey
3Department of Ecology and Evolutionary Biology, University of Chicago, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Cobey
Jaline Gerardin
6Department of Preventive Medicine and Institute for Global Health, Northwestern University, Chicago IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jaline Gerardin
  • For correspondence: jgerardin@northwestern.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Availability of SARS-CoV-2 testing in the United States (U.S.) has fluctuated through the course of the COVID-19 pandemic, including in the U.S. state of Illinois. Despite substantial ramp-up in test volume, access to SARS-CoV-2 testing remains limited, heterogeneous, and insufficient to control spread.

Methods We compared SARS-CoV-2 testing rates across geographic regions, over time, and by demographic characteristics (i.e., age and racial/ethnic groups) in Illinois during March through December 2020. We compared age-matched case fatality ratios and infection fatality ratios through time to estimate the fraction of SARS-CoV-2 infections that have been detected through diagnostic testing.

Results By the end of 2020, initial geographic differences in testing rates had closed substantially. Case fatality ratios were higher in non-Hispanic Black and Hispanic/Latino populations in Illinois relative to non-Hispanic White populations, suggesting that tests were insufficient to accurately capture the true burden of COVID-19 disease in the minority populations during the initial epidemic wave. While testing disparities decreased during 2020, Hispanic/Latino populations consistently remained the least tested at 1.87 tests per 1000 population per day compared with 2.58 and 2.87 for non-Hispanic Black and non-Hispanic White populations, respectively, at the end of 2020. Despite a large expansion in testing since the beginning of the first wave of the epidemic, we estimated that over half (50-80%) of all SARS-CoV-2 infections were not detected by diagnostic testing and continued to evade surveillance.

Conclusions Systematic methods for identifying relatively under-tested geographic regions and demographic groups may enable policymakers to regularly monitor and evaluate the shifting landscape of diagnostic testing, allowing officials to prioritize allocation of testing resources to reduce disparities in COVID-19 burden and eventually reduce SARS-CoV-2 transmission.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

TH was supported by a grant from NIGMS (T32 GM008152). RR was supported by a grant from NIGMS (T32 GM008449). MR was supported by a COVID-19 rapid response grant via NUCATS (UL1TR001422). The funders had no role in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was carried out as part of a Medical Study (Modeling COVID-19 Epidemiologic Trend and Health Care Impact in Illinois) declared by the Illinois Department of Public Health (IDPH) on March 23, 2020. All data collection was performed by IDPH as part of routine surveillance for COVID-19 and was deidentified prior to analysis. CDC has determined that this study does not constitute human subjects research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Data Availability

The I-NEDSS and testing by age and race/ethnicity datasets analyzed in this study were used under license for the current study, and so are not publicly available. Restrictions apply to the availability of these data, which contain identifiable private health information. Interested parties should contact IDPH to inquire about access. Public data on cases and testing are available from IDPH (https://www.dph.illinois.gov/covid19/covid19-statistics) and from other public aggregators (https://coronavirus.jhu.edu/region/us/illinois).

https://www.dph.illinois.gov/covid19/covid19-statistics

https://coronavirus.jhu.edu/region/us/illinois

  • List of abbreviations

    ACS
    American Community Survey
    CFR
    case fatality ratio
    HFR
    hospital fatality ratio
    IDPH
    Illinois Department of Public Health
    IFR
    infection fatality ratio
    I-NEDSS
    Illinois’s National Electronic Disease Surveillance System
    NCHS
    National Center for Health Statistics
    UIUC
    University of Illinois at Urbana-Champaign
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted April 20, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
    Tobias M Holden, Reese A.K. Richardson, Philip Arevalo, Wayne A. Duffus, Manuela Runge, Elena Whitney, Leslie Wise, Ngozi O. Ezike, Sarah Patrick, Sarah Cobey, Jaline Gerardin
    medRxiv 2021.04.14.21255476; doi: https://doi.org/10.1101/2021.04.14.21255476
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
    Tobias M Holden, Reese A.K. Richardson, Philip Arevalo, Wayne A. Duffus, Manuela Runge, Elena Whitney, Leslie Wise, Ngozi O. Ezike, Sarah Patrick, Sarah Cobey, Jaline Gerardin
    medRxiv 2021.04.14.21255476; doi: https://doi.org/10.1101/2021.04.14.21255476

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Public and Global Health
    Subject Areas
    All Articles
    • Addiction Medicine (269)
    • Allergy and Immunology (549)
    • Anesthesia (135)
    • Cardiovascular Medicine (1749)
    • Dentistry and Oral Medicine (238)
    • Dermatology (172)
    • Emergency Medicine (310)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
    • Epidemiology (10785)
    • Forensic Medicine (8)
    • Gastroenterology (584)
    • Genetic and Genomic Medicine (2935)
    • Geriatric Medicine (286)
    • Health Economics (531)
    • Health Informatics (1919)
    • Health Policy (833)
    • Health Systems and Quality Improvement (743)
    • Hematology (290)
    • HIV/AIDS (627)
    • Infectious Diseases (except HIV/AIDS) (12501)
    • Intensive Care and Critical Care Medicine (684)
    • Medical Education (299)
    • Medical Ethics (86)
    • Nephrology (322)
    • Neurology (2785)
    • Nursing (150)
    • Nutrition (431)
    • Obstetrics and Gynecology (556)
    • Occupational and Environmental Health (597)
    • Oncology (1458)
    • Ophthalmology (441)
    • Orthopedics (172)
    • Otolaryngology (255)
    • Pain Medicine (190)
    • Palliative Medicine (56)
    • Pathology (380)
    • Pediatrics (865)
    • Pharmacology and Therapeutics (362)
    • Primary Care Research (334)
    • Psychiatry and Clinical Psychology (2633)
    • Public and Global Health (5342)
    • Radiology and Imaging (1004)
    • Rehabilitation Medicine and Physical Therapy (595)
    • Respiratory Medicine (724)
    • Rheumatology (329)
    • Sexual and Reproductive Health (289)
    • Sports Medicine (278)
    • Surgery (327)
    • Toxicology (47)
    • Transplantation (149)
    • Urology (125)